Bioray Biotech Co

Bioray Biotech Co Current Ratio

The Current Ratio of Bioray Biotech Co (7561.TWO) as of Oct 21, 2026 is 17.93. In the previous year, Current Ratio was 4.89 — a change of 266.71% (higher).

Current Ratio

17.93

YoY

266.71%

Last updated:

Current Ratio of Bioray Biotech Co is 2025 17.93 . Current Ratio of Bioray Biotech Co was 2024 4.89 . It decreases by 266.71% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioray Biotech Co Stock analysis

What does Bioray Biotech Co do? BioRay Biotech Co., Ltd. generates revenue through its biological health products, functional medical testing services, and cell storage and preparation offerings. The company sells personalized probiotics, anti-allergic and intestinal probiotics, diabetes probiotics, female urinary tract products, and anti-arthritis probiotics. Functional medical testing includes personalized bacteria, personalized fungi, intestinal normal bacteria, quantitative magnesium detection in red blood cells, metabolic gene polymorphism analysis, and lymphocyte grouping. Cell storage services feature stem cell storage, immune cell storage, and cytokine induced killer (CIK) immune cell preparations. The primary customers for these products and services are individuals seeking personalized health solutions, including those managing chronic conditions like diabetes or arthritis. The company targets health-conscious consumers and medical professionals requiring specialized testing and cell-based therapies. BioRay Biotech focuses on delivering tailored health and medical services through its integrated product and service portfolio. Revenue streams are derived from direct sales of health products, testing service fees, and cell storage contracts. The business model emphasizes customization, with each product and service segment catering to specific health needs. The company’s offerings are structured to address individual health challenges through scientific and personalized approaches. Bioray Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioray Biotech Co stock

Current Ratio of Bioray Biotech Co is 17.93 in 2025.

Current Ratio of Bioray Biotech Co changed from 4.89 to 17.93, representing a 266.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Bioray Biotech Co since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Bioray Biotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Bioray Biotech Co

All Key Metrics — Bioray Biotech Co